The effect of Tecar therapy on neurological disorders and nerve conduction velocity of lower limbs in peripheral neuropathy of type 2 diabetic patients: A six-week follow-up study

• Published in: Turkish journal of physical medicine and rehabilitation 2023-12, Vol.69 (4), p.479-487
• Main Authors: Niajalili, Maryam, Mohsen Roostayi, Mohamad, Daryabor, Aliyeh, Naimi, Sedigheh Sadat, Amoli, Mitra Javan
• Format: Article
• Language: eng ; tur
• Subjects: Analysis; Care and treatment; Diabetic neuropathies; Diabetics; Nervous system diseases; Original; Type 2 diabetes
• ISSN: 2587-1250; 1302-0234; 2587-0823; 2587-0823
• DOI: 10.5606/tftrd.2023.11875

This study aimed to investigate the effect of Tecar therapy on neuropathy symptoms and tibial nerve conduction velocity in individuals with diabetes. The single-blind, randomized, sham-controlled clinical trial was conducted between January 2019 and October 2019. Twenty-four type 2 diabetics (8 males, 16 females; mean age: 60.4±8.9 years; range, 40 to 78 years) with peripheral neuropathy were randomly allocated to control (n=12) and study (n=12) groups. The study group received the capacitive Tecar therapy with 10 to 30% intensity and infrared radiation in 10 sessions. The controls received the same protocol with zero intensity. The neuropathy symptoms and nerve conduction velocity were evaluated at baseline, after 10 sessions, and six weeks after the end of sessions. There were no significant differences in variables (p>0.05). In this way, the homogeneity of the data variables was confirmed. Moreover, the results of two-way mixed analysis of variance showed that improvement of neuropathy symptoms in the study group was significantly more than controls in all stages (p